Ostrom QT, Price M, Neff C et al (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol 25(Supplement_4):iv1–iv99

Article  PubMed  Google Scholar 

Korja M, Raj R, Seppa K, Luostarinen T, Malila N, Seppala M, Maenpaa H, Pitkaniemi J (2018) Glioblastoma survival is improving despite increasing incidence rates: A nationwide study between 2000 and 2013 in Finland. Available at SSRN: https://doi.org/10.2139/ssrn.3207930

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

Article  CAS  PubMed  Google Scholar 

Lakomy R, Kazda T, Selingerova I et al (2020) Real-world evidence in glioblastoma: stupp’s regimen after a decade. Front Oncol 10:840

Article  PubMed  PubMed Central  Google Scholar 

Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2(11):1460–1469

Article  PubMed  PubMed Central  Google Scholar 

Trifiletti DM, Alonso C, Grover S, Fadul CE, Sheehan JP, Showalter TN (2017) Prognostic implications of extent of resection in glioblastoma: analysis from a large database. World Neurosurg 103:330–340

Article  PubMed  Google Scholar 

Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8

Article  PubMed  Google Scholar 

Chaichana KL, Jusue-Torres I, Navarro-Ramirez R et al (2014) Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 16(1):113–122

Article  PubMed  Google Scholar 

National Cancer Database. ACS. https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/. Accessed 13 Feb 2023

World Health Organization WHO (2013) International classification of diseases for oncology (ICD-O), 3rd edn., 1st revision. Geneva, Switzerland. https://apps.who.int/iris/handle/10665/96612. Accessed Feb 2024

Zhu P, Du XL, Zhu JJ, Esquenazi Y (2019) Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. J Neurosurg 132(2):491–502

Article  PubMed  Google Scholar 

Zhu P, Du X, Blanco A et al (2020) Epid-34. The detrimental effect of biopsy preceding resection in surgically accessible glioblastomas: results from the National Cancer Database. Neuro Oncol 22(Supplement_2):ii85–ii86

PubMed Central  Google Scholar 

Zhu P, Du XL, Blanco AI et al (2019) Impact of facility type and volume in low-grade glioma outcomes. J Neurosurg 1–11. https://doi.org/10.3171/2019.6.JNS19409

Krex D, Klink B, Hartmann C et al (2007) Long-term survival with glioblastoma multiforme. Brain 130(Pt 10):2596–2606

Article  PubMed  Google Scholar 

Sonoda Y, Kumabe T, Watanabe M et al (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 151(11):1349–1358

Article  PubMed  Google Scholar 

Han Q, Liang H, Cheng P, Yang H, Zhao P (2020) Gross total vs. subtotal resection on survival outcomes in elderly patients with high-grade glioma: a systematic review and meta-analysis. Front Oncol 10:151

Article  PubMed  PubMed Central  Google Scholar 

Karschnia P, Young JS, Dono A et al (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group. Neuro Oncol 25(5):940–954. https://doi.org/10.1093/neuonc/noac193

Molinaro AM, Hervey-Jumper S, Morshed RA et al (2020) Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol 6(4):495. https://doi.org/10.1001/jamaoncol.2019.6143

Article  PubMed  PubMed Central  Google Scholar 

Lopez-Rivera V, Dono A, Lewis CT et al (2021) Extent of resection and survival outcomes of geriatric patients with glioblastoma: is there benefit from aggressive surgery? Clin Neurol Neurosurg 202:106474

Article  PubMed  Google Scholar 

Weller M, van den Bent M, Tonn JC et al (2017) European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol 18(6):e315–e329

Article  PubMed  Google Scholar 

Barker FG 2nd, Chang SM, Gutin PH et al (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42(4):709–720 (discussion 720-3)

Article  PubMed  Google Scholar 

Ringel F, Pape H, Sabel M et al (2016) Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol 18(1):96–104

Article  PubMed  Google Scholar 

van Linde ME, Brahm CG, de Witt Hamer PC et al (2017) Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis. J Neurooncol 135(1):183–192

Article  PubMed  PubMed Central  Google Scholar 

Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg 129(5):1231–1239

Article  PubMed  PubMed Central  Google Scholar 

D’Amico RS, Cloney MB, Sonabend AM et al (2015) The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurg 84(4):913–919

Article  PubMed  Google Scholar 

Morshed RA, Young JS, Gogos AJ et al (2022) Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature. Acta Neurochir 164(2):405–417

Article  PubMed  Google Scholar 

Lu VM, Goyal A, Graffeo CS et al (2019) Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-analysis. World Neurosurg 127:31–37

Article  PubMed  Google Scholar 

Lu VM, Jue TR, McDonald KL, Rovin RA (2018) The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis. World Neurosurg 115:453-459.e3

Article  PubMed  Google Scholar 

Baron RB, Kessler RA, Hadjipanayis CG (2019) Initial biopsy and early re-resection practices in the treatment of glioblastoma among AANS/CNS tumor section surgeons. J Neurooncol 144(3):529–534

Article  PubMed  Google Scholar 

Kim AA, Dono A, Khalafallah AM et al (2022) Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons. J Neurosurg 137(6):1618–1627

Article  CAS  PubMed  Google Scholar 

Chaichana KL, Garzon-Muvdi T, Parker S et al (2011) Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 18(1):239–245

Article  PubMed  Google Scholar 

Noorbakhsh A, Tang JA, Marcus LP et al (2014) Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg 120(1):31–39

Article  PubMed  Google Scholar 

Goel NJ, Bird CE, Hicks WH, Abdullah KG (2021) Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment. J Med Econ 24(1):1018–1024

Article  PubMed  Google Scholar 

Xiao N, Zhu D, Xiao S (2018) Effects of continued psychological care toward brain tumor patients and their family members’ negative emotions. J Cancer Res Ther 14(Supplement):S202–S207

Article  PubMed  Google Scholar 

Starowicz-Filip A, Prochwicz K, Myszka A et al (2022) Subjective experience, cognitive functioning and trauma level of patients undergoing awake craniotomy due to brain tumor - preliminary study. Appl Neuropsychol Adult 29(5):983–992

Article  PubMed  Google Scholar 

Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi O, Rosen B (2014) Advanced magnetic resonance imaging of the physical processes in human glioblastoma. Cancer Res 74(17):4622–4637

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawrence YR, Mishra MV, Werner-Wasik M et al (2012) Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer 118(17):4228–4234

Article  PubMed  Google Scholar 

Hong MAC, Omar AT, Khu KJO (2022) Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines. J Clin Neurosci 98:89–95

Article  PubMed  Google Scholar 

Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59(suppl_1):i11–i18

Article  PubMed  PubMed Central  Google Scholar 

Overcast WB, Davis KM, Ho CY et al (2021) Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors. Curr Oncol Rep 23(3):34

Article  PubMed  PubMed Central  Google Scholar 

Shukla G, Alexander GS, Bakas S et al (2017) Advanced magnetic resonance imaging in glioblastoma: a review. Chin Clin Oncol 6(4):40

Article  PubMed  Google Scholar 

Eibl RH, Schneemann M (2023) Liquid biopsy and glioblastoma. Explor Target Antitumor Ther 4(1):28–41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ronvaux L, Riva M, Coosemans A et al (2022) Liquid biopsy in glioblastoma. Cancers 14(14).